Coronary Artery Disease (Left Main) Clinical Trial
Official title:
Multicenter Prospective Clinical Study of the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease
Prospective, non-randomized, multi-center study assessing the long term safety and efficacy of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected left main coronary artery disease.
In the treatment of unprotected left main coronary artery (ULMCA) disease, previous
mono-center studies have shown promising results with the previous generation of the
self-expandable STENTYS stent (paclitaxel eluting stent, delivered via withdrawal of a
sheath).
The TRUNC study aims at assessing at large scale the Xposition S in the treatment of ULMCA
disease. The Xposition S is a sirolimus eluting stent, mounted on a balloon delivery system.
The study aims at collecting clinical practice routine data from 200 patients.
;
Observational Model: Case-Only, Time Perspective: Prospective